1. Home
  2. AMPX vs DNLI Comparison

AMPX vs DNLI Comparison

Compare AMPX & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amprius Technologies Inc.

AMPX

Amprius Technologies Inc.

HOLD

Current Price

$17.87

Market Cap

2.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$19.66

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPX
DNLI
Founded
2008
2013
Country
United States
United States
Employees
109
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AMPX
DNLI
Price
$17.87
$19.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$20.17
$34.33
AVG Volume (30 Days)
8.5M
1.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$76.15
N/A
Revenue Next Year
$59.65
$408.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$12.58
52 Week High
$22.80
$23.77

Technical Indicators

Market Signals
Indicator
AMPX
DNLI
Relative Strength Index (RSI) 46.38 49.60
Support Level $10.00 $18.86
Resistance Level $19.76 $20.35
Average True Range (ATR) 1.74 1.00
MACD -0.55 0.04
Stochastic Oscillator 33.49 62.96

Price Performance

Historical Comparison
AMPX
DNLI

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. Its silicon anodes are a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and its manufacturing processes leverage the manufacturing processes for conventional lithium-ion batteries and the related supply chain.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: